Type II CRISPR/Cas9 approach in the oncological therapy.
Biagioni A, Chillà A, Andreucci E, Laurenzana A, Margheri F, Peppicelli S, Del Rosso M, Fibbi G.
Biagioni A, et al. Among authors: del rosso m.
J Exp Clin Cancer Res. 2017 Jun 15;36(1):80. doi: 10.1186/s13046-017-0550-0.
J Exp Clin Cancer Res. 2017.
PMID: 28619109
Free PMC article.
Review.